| CAS ID: | 827611-49-4 |
| Molecular Formula: | C13H17N5O8S2 |
| Molecular Weight: | 435.4 g/mol |
| Monoisotopic Mass: | 435.0519 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | SO 26776 | AZTREONAM LYSINE | CAYSTON | SQ-26776 | Corus 1020 | AZTREONAM | Azactam |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C13H17N5O8S2/c1-5-7(10(20)18(5)28(23,24)25)16-9(19)8(6-4-27-12(14)15-6)17-26-13(2,3)11(21)22/h4-5,7H,1-3H3,(H2,14,15)(H,16,19)(H,21,22)(H,23,24,25)/b17-8-/t5-,7-/m0/s1 | See All |
| InChI Key: | WZPBZJONDBGPKJ-VEHQQRBSSA-N | |
| Smiles: | C[C@H]1[C@H](NC(=O)\C(=N/OC(C)(C)C(=O)O)\c2csc(N)n2)C(=O)N1S(=O)(=O)O | See All |
| Molfile: |
Trial Record 1
| ClinicalTrial ID | NCT00989807 | Disease | Cystic fibrosis |
| Phase | Status | - | |
| First Received | October 6, 2009 | Last Verified | December 13, 2012 |
| Sponsor | Gilead Sciences | ||
Trial Record 2
| ClinicalTrial ID | NCT00499720 | Disease | Cystic fibrosis |
| Phase | Status | - | |
| First Received | July 11, 2007 | Last Verified | August 2, 2011 |
| Sponsor | Gilead Sciences | ||